JP7451779B2 - 血液分析装置および血液分析方法 - Google Patents
血液分析装置および血液分析方法 Download PDFInfo
- Publication number
- JP7451779B2 JP7451779B2 JP2023001491A JP2023001491A JP7451779B2 JP 7451779 B2 JP7451779 B2 JP 7451779B2 JP 2023001491 A JP2023001491 A JP 2023001491A JP 2023001491 A JP2023001491 A JP 2023001491A JP 7451779 B2 JP7451779 B2 JP 7451779B2
- Authority
- JP
- Japan
- Prior art keywords
- blood cells
- red blood
- malaria
- sample
- measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 title claims description 142
- 239000008280 blood Substances 0.000 title claims description 142
- 238000000034 method Methods 0.000 title claims description 91
- 238000004159 blood analysis Methods 0.000 title claims description 18
- 210000003743 erythrocyte Anatomy 0.000 claims description 314
- 201000004792 malaria Diseases 0.000 claims description 260
- 238000005259 measurement Methods 0.000 claims description 177
- 239000002245 particle Substances 0.000 claims description 166
- 150000007523 nucleic acids Chemical class 0.000 claims description 131
- 102000039446 nucleic acids Human genes 0.000 claims description 131
- 108020004707 nucleic acids Proteins 0.000 claims description 131
- 238000009826 distribution Methods 0.000 claims description 86
- 210000004027 cell Anatomy 0.000 claims description 51
- 238000010586 diagram Methods 0.000 claims description 42
- 239000007850 fluorescent dye Substances 0.000 claims description 26
- 239000003085 diluting agent Substances 0.000 claims description 21
- 208000030852 Parasitic disease Diseases 0.000 claims description 12
- 230000036281 parasite infection Effects 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 235000005811 Viola adunca Nutrition 0.000 claims description 6
- 240000009038 Viola odorata Species 0.000 claims description 6
- 235000013487 Viola odorata Nutrition 0.000 claims description 6
- 235000002254 Viola papilionacea Nutrition 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 181
- 210000003000 inclusion body Anatomy 0.000 description 109
- 238000012545 processing Methods 0.000 description 33
- 244000045947 parasite Species 0.000 description 30
- 238000001514 detection method Methods 0.000 description 28
- 238000003860 storage Methods 0.000 description 26
- 210000000265 leukocyte Anatomy 0.000 description 24
- 210000000601 blood cell Anatomy 0.000 description 20
- 210000002109 erythrocyte inclusion Anatomy 0.000 description 20
- 230000005856 abnormality Effects 0.000 description 16
- 230000001640 apoptogenic effect Effects 0.000 description 16
- 238000012795 verification Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 230000003287 optical effect Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000010365 information processing Effects 0.000 description 13
- 239000012128 staining reagent Substances 0.000 description 10
- 210000001772 blood platelet Anatomy 0.000 description 8
- 210000001995 reticulocyte Anatomy 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 210000001563 schizont Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 210000003936 merozoite Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 4
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000000973 gametocyte Anatomy 0.000 description 4
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 4
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 description 4
- 210000003812 trophozoite Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000255925 Diptera Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 230000006882 induction of apoptosis Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 2
- 210000001808 exosome Anatomy 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- VMCOQLKKSNQANE-UHFFFAOYSA-N n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 VMCOQLKKSNQANE-UHFFFAOYSA-N 0.000 description 2
- 210000000948 non-nucleated cell Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 101100460719 Mus musculus Noto gene Proteins 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1497—Particle shape
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Signal Processing (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
実施形態1の血液分析装置10は、血液検体と試薬とから調製された測定試料を測定して、マラリア原虫に感染した赤血球を含む集団を特定し、血液検体がマラリアに感染しているか否かを判定する。
発明者らが、図5(b)に示すマラリア感染赤血球に対応する領域203に、細胞外小胞の一種であるアポトーシス小体と、核酸の封入体の一種であるハウウェルジョリー小体を含む赤血球とが分布することを見いだした経緯について説明する。核酸の封入体を含む赤血球とは、細胞の内部で核酸が凝集して残った核酸の封入体を含む赤血球である。なお、網赤血球においては、内部に存在するRNAは網赤血球内で分散しており、核酸は凝集体としては存在しない。したがって、網赤血球は、核酸の封入体を含む赤血球とは異なるものである。
・培地:10% FBS添加 RPMI1640培地
・細胞溶液:1×106/μL程度まで培養したJurkat細胞を培地で10倍希釈し、24時間培養
(アポトーシス誘導)
・誘導剤:Staurosporine 1μM
・Stock solution:250μg/500μL DMSO(1mMStaurosporine)
・1mM Staurosporineを培地で10倍希釈した100μM Staurosporine溶液を作成し、培養液に対して1/100量添加
実施形態2では、判定処理において、マラリアの有無だけでなく、核酸の封入体を含む赤血球、および細胞外小胞の少なくとも一方の有無についても判定される。実施形態2および後述する実施形態3において「核酸の封入体を含む赤血球、および細胞外小胞の少なくとも一方の有無を判定する」とは、核酸の封入体を含む赤血球、または細胞外小胞の有無を判定すること、すなわち核酸の封入体を含む赤血球、および細胞外小胞のうち少なくとも一方があるか否かを判定することを示す。実施形態2の判定処理は、図6に示した実施形態1の判定処理と比較して、判定内容が異なっているものの、図16に示すように、略同様に構成されている。実施形態2のその他の構成は、実施形態1と同様である。
実施形態3では、判定処理において、核酸の封入体を含む赤血球、および細胞外小胞の少なくとも一方の有無について判定される。上述したように、スキャッタグラム200において、マラリア感染赤血球に対応する領域203には、核酸の封入体を含む赤血球、または細胞外小胞が分布する場合がある。実施形態3では、図18に示すように、スキャッタグラム400において、核酸の封入体を含む赤血球、および細胞外小胞に対応する領域403が設けられている。また、実施形態3の判定処理は、図19に示すように構成される。実施形態3のその他の構成は、実施形態1と同様である。
30 試料調製部
51 制御部
53 出力部
53a 表示部
101 フローセル
102 光源
103、105 受光部
400 スキャッタグラム
403 領域
500 度数分布図
G6 粒子群
Claims (20)
- 血液検体と核酸を染色する蛍光色素とを混合して測定試料を調製し、調製された前記測定試料に光を照射して前記測定試料中の粒子から生じる蛍光強度および散乱光強度を含む測定データを生成する測定部と、
前記測定データに含まれる蛍光強度および散乱光強度に基づいて特徴空間に粒子をプロットし、前記特徴空間においてマラリア感染赤血球が現れる領域にプロットされる粒子を計数する制御部と、を備え、
前記制御部は、第1の量の前記測定試料を測定して得られた第1の測定データに基づいて前記マラリア感染赤血球が現れる領域にプロットされる粒子の数が閾値未満である場合、前記第1の量より多い第2の量の前記測定試料を測定するよう前記測定部を制御する、血液分析装置。 - 前記制御部は、前記測定部が前記第2の量の測定試料を測定して得られた第2の測定データに基づいて、マラリア原虫の感染に関する判定結果を取得する、請求項1に記載の血液分析装置。
- 前記制御部は、前記第1の測定データに基づいて前記マラリア感染赤血球が現れる領域にプロットされる粒子の数が閾値以上である場合、前記第1の測定データに基づいてマラリア原虫の感染に関する判定結果を取得する、請求項1に記載の血液分析装置。
- 前記制御部は、前記特徴空間においてシングルリングフォーム赤血球が現れる領域にプロットされる粒子の分布のばらつきを示す値を取得し、その値に基づいてマラリア原虫の感染に関する判定結果を取得する、請求項1に記載の血液分析装置。
- 前記制御部は、前記ばらつきを示す値と、マラリア感染赤血球が現れる領域に含まれる粒子数とに基づいて、マラリア原虫の感染の有無に関する判定結果を取得する、請求項4に記載の血液分析装置。
- 前記ばらつきを示す値は、シングルリングフォーム赤血球が現れる領域にプロットされる粒子の蛍光強度に対する度数分布のばらつきを示す値である、請求項5に記載の血液分析装置。
- 前記ばらつきを示す値は、変動係数、標準偏差または度数分布図の半値幅である、請求項5に記載の血液分析装置。
- 前記試料調製部は、赤血球を収縮させる希釈液を混合して前記測定試料を調製する、請求項1に記載の血液分析装置。
- 前記光源は、青紫色波長帯域の光を出射する、請求項1に記載の血液分析装置。
- 前記蛍光強度および前記散乱光強度に基づくスキャッタグラムを表示する表示部をさらに備える、請求項1に記載の血液分析装置。
- 血液検体と核酸を染色する蛍光色素とを混合して測定試料を調製し、
調製された前記測定試料のうち第1の量の測定試料をフローセルに流し、前記フローセルを流れる前記測定試料に対して光を照射し、
前記測定試料中の粒子から生じる蛍光強度および散乱光強度を測定し、
蛍光強度および散乱光強度に基づいて特徴空間に粒子をプロットし、
前記特徴空間においてマラリア感染赤血球が現れる領域にプロットされる粒子の数が閾値未満である場合、前記第1の量より多い第2の量の測定試料を前記フローセルに流し、第2の量の測定試料中の粒子から得られる蛍光強度および散乱光強度に基づいて、前記血液検体中のマラリア感染赤血球の有無を判定する、血液分析方法。 - 前記第2の量の測定試料を測定して得られた、前記マラリア感染赤血球が現れる領域にプロットされる粒子の数に基づいて、前記血液検体中のマラリア感染赤血球の有無を判定する、請求項11に記載の血液分析方法。
- 第1の量の測定試料を測定したときの前記マラリア感染赤血球が現れる領域にプロットされる粒子の数が閾値以上である場合、前記第1の量の測定試料中の粒子から得られる蛍光強度および散乱光強度に基づいてマラリア原虫の感染に関する判定結果を取得する、請求項11に記載の血液分析方法。
- 前記特徴空間においてシングルリングフォーム赤血球が現れる領域にプロットされる粒子の分布のばらつきを示す値を取得し、その値に基づいて前記血液検体中のマラリア感染赤血球の有無を判定する、請求項11に記載の血液分析方法。
- 前記ばらつきを示す値と、マラリア感染赤血球が現れる領域に含まれる粒子数とに基づいて、前記血液検体中のマラリア感染赤血球の有無を判定する、請求項14に記載の血液分析方法。
- 前記ばらつきを示す値は、シングルリングフォーム赤血球が現れる領域にプロットされる粒子の蛍光強度に対する度数分布のばらつきを示す値である、請求項15に記載の血液分析方法。
- 前記ばらつきを示す値は、変動係数、標準偏差または度数分布図の半値幅である、請求項15に記載の血液分析方法。
- 前記測定試料の調製は、血液検体にさらに赤血球を収縮させる希釈液を混合することを含む、請求項11に記載の血液分析方法。
- 前記測定試料に照射される光は、青紫色波長帯域の光である、請求項11に記載の血液分析方法。
- 前記蛍光強度および前記散乱光強度に基づくスキャッタグラムを表示することをさらに含む、請求項11に記載の血液分析方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016145834 | 2016-07-25 | ||
JP2016145834 | 2016-07-25 | ||
JP2017118936A JP6896516B2 (ja) | 2016-07-25 | 2017-06-16 | 血液分析装置および血液分析方法 |
JP2021096948A JP7209771B2 (ja) | 2016-07-25 | 2021-06-09 | 血液分析装置および血液分析方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021096948A Division JP7209771B2 (ja) | 2016-07-25 | 2021-06-09 | 血液分析装置および血液分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023041700A JP2023041700A (ja) | 2023-03-24 |
JP7451779B2 true JP7451779B2 (ja) | 2024-03-18 |
Family
ID=59409202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023001491A Active JP7451779B2 (ja) | 2016-07-25 | 2023-01-10 | 血液分析装置および血液分析方法 |
Country Status (4)
Country | Link |
---|---|
US (2) | US10451638B2 (ja) |
EP (1) | EP3276330B1 (ja) |
JP (1) | JP7451779B2 (ja) |
CN (1) | CN107655865B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3094577A1 (en) * | 2018-03-30 | 2019-10-03 | Exosomics S.p.A. | Use of hollow fibers to obtain blood or a blood derivative impoverished from blood cells and platelets derived extracellular vesicles |
WO2020042027A1 (zh) * | 2018-08-29 | 2020-03-05 | 深圳迈瑞生物医疗电子股份有限公司 | 血液样本检测的方法、血液样本检测仪和存储介质 |
JP2020134341A (ja) * | 2019-02-20 | 2020-08-31 | シスメックス株式会社 | 測定成否判定方法および試料測定装置 |
CN118475824A (zh) * | 2021-12-31 | 2024-08-09 | 深圳迈瑞生物医疗电子股份有限公司 | 血液细胞分析仪、提示感染状态的方法以及感染标志参数的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004105027A (ja) | 2002-09-13 | 2004-04-08 | Sysmex Corp | マラリア原虫測定方法及び装置 |
JP2006304774A (ja) | 2005-03-29 | 2006-11-09 | Sysmex Corp | マラリア感染赤血球の検出方法並びにこれに使用する検出用試薬及び赤血球膜部分溶解試薬 |
US20140308697A1 (en) | 2011-10-31 | 2014-10-16 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Methods and apparatuses for identifying red blood cells infected by plasmodium |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1406088A3 (en) * | 2002-10-04 | 2004-04-14 | Sysmex Corporation | Reagent kits and methods for detecting malaria parasites by two-steps surfactant-mediated hemolysis |
JP4388779B2 (ja) | 2002-10-04 | 2009-12-24 | シスメックス株式会社 | マラリア原虫の検出方法、検出装置、およびその試薬キット |
ES2439728T3 (es) * | 2005-03-29 | 2014-01-24 | Sysmex Corporation | Un reactivo para lisar parcialmente una membrana celular de un glóbulo rojo, un reactivo para detectar glóbulos rojos infectados de malaria, y un método para analizar muestras para detectar glóbulos rojos infectados de malaria |
EP2280278A4 (en) * | 2008-05-09 | 2015-04-08 | Sysmex Corp | BLOOD ANALYSIS DEVICE, BLOOD ANALYSIS METHOD, AND HEMOLYTIC AGENT |
JP5670052B2 (ja) | 2009-03-26 | 2015-02-18 | シスメックス株式会社 | 血液分析装置、血液分析方法及びコンピュータプログラム |
WO2012147451A1 (ja) * | 2011-04-28 | 2012-11-01 | シスメックス株式会社 | 血液分析装置、血液分析方法、及びコンピュータプログラム |
JP6461494B2 (ja) | 2014-06-19 | 2019-01-30 | シスメックス株式会社 | 血液分析装置、血液分析方法及び血液分析プログラム |
JP6383216B2 (ja) * | 2014-08-08 | 2018-08-29 | シスメックス株式会社 | 血液分析方法、血液分析装置およびプログラム |
JP6612050B2 (ja) | 2014-08-28 | 2019-11-27 | シスメックス株式会社 | 血液分析装置、診断支援方法、およびコンピュータプログラム |
JP6635720B2 (ja) | 2015-08-31 | 2020-01-29 | シスメックス株式会社 | 血液分析装置及び血液分析方法 |
-
2017
- 2017-07-21 CN CN201710602108.1A patent/CN107655865B/zh active Active
- 2017-07-24 US US15/657,962 patent/US10451638B2/en active Active
- 2017-07-25 EP EP17182965.8A patent/EP3276330B1/en active Active
-
2019
- 2019-09-27 US US16/585,982 patent/US11002746B2/en active Active
-
2023
- 2023-01-10 JP JP2023001491A patent/JP7451779B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004105027A (ja) | 2002-09-13 | 2004-04-08 | Sysmex Corp | マラリア原虫測定方法及び装置 |
JP2006304774A (ja) | 2005-03-29 | 2006-11-09 | Sysmex Corp | マラリア感染赤血球の検出方法並びにこれに使用する検出用試薬及び赤血球膜部分溶解試薬 |
US20140308697A1 (en) | 2011-10-31 | 2014-10-16 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Methods and apparatuses for identifying red blood cells infected by plasmodium |
Non-Patent Citations (2)
Title |
---|
Howard M. Shapiro et al.,Cytometry in Malaria?A Practical Replacement for Microscopy?,Curr Protoc Cytom.,2013年,Chapter 11:11.20.1-11.20.23. |
Pierre-Yves Mantel et al.,Malaria infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system,Cell Host Microbe.,2013年,Vol.13, No.5,521-534 |
Also Published As
Publication number | Publication date |
---|---|
CN107655865B (zh) | 2021-10-19 |
EP3276330A1 (en) | 2018-01-31 |
US20200025778A1 (en) | 2020-01-23 |
EP3276330B1 (en) | 2020-03-25 |
US10451638B2 (en) | 2019-10-22 |
US20180024148A1 (en) | 2018-01-25 |
JP2023041700A (ja) | 2023-03-24 |
US11002746B2 (en) | 2021-05-11 |
CN107655865A (zh) | 2018-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7451779B2 (ja) | 血液分析装置および血液分析方法 | |
US9328375B2 (en) | Blood analyzer, blood analysis method, hemolytic agent and staining agent | |
US20140322750A1 (en) | Blood analyzer, blood analysis method and hemolytic agent | |
CN106483109B (zh) | 血液分析装置及血液分析方法 | |
JP7209771B2 (ja) | 血液分析装置および血液分析方法 | |
JP7291337B2 (ja) | 骨髄液分析方法、試料分析装置及びコンピュータプログラム | |
US10241048B2 (en) | Blood analyzing method and blood analyzer | |
US10295553B2 (en) | Blood analyzing method as well as stain solution and blood analyzer used for the same | |
CN106483101B (zh) | 尿样本分析装置及尿样本分析方法 | |
JP2006101708A (ja) | マラリア感染赤血球の測定方法、測定装置、測定用試薬、及びマラリア原虫の測定方法、測定装置、測定用試薬 | |
JP7425597B2 (ja) | 血液分析方法 | |
JP6871729B2 (ja) | マラリア原虫に感染した赤血球の検出方法及び血液分析装置 | |
JP2005333868A (ja) | マラリア原虫測定方法及び測定装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230201 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231027 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240206 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240306 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7451779 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |